Compare EHAB & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EHAB | CLPT |
|---|---|---|
| Founded | 2014 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 690.3M | 494.6M |
| IPO Year | 2020 | 2009 |
| Metric | EHAB | CLPT |
|---|---|---|
| Price | $13.61 | $10.74 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | $13.84 | ★ $21.50 |
| AVG Volume (30 Days) | ★ 2.3M | 930.3K |
| Earning Date | 01-01-0001 | 04-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 97.11 | 22.22 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,060,000,000.00 | $31,390,000.00 |
| Revenue This Year | $6.23 | $18.93 |
| Revenue Next Year | $4.35 | $51.64 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 2.44 | ★ 31.04 |
| 52 Week Low | $6.47 | $8.63 |
| 52 Week High | $13.66 | $30.10 |
| Indicator | EHAB | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 79.70 | 41.50 |
| Support Level | $10.79 | $10.57 |
| Resistance Level | $13.64 | $11.69 |
| Average True Range (ATR) | 0.03 | 1.01 |
| MACD | -0.06 | -0.02 |
| Stochastic Oscillator | 50.00 | 31.38 |
Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services for adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing a life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.